After an incredible performance in late March, when shares of Acadia Pharmaceuticals (ACAD 0.35%) jumped up 23%, they have once again exploded today, up 40% intraday. What's behind these massive leaps for this pharmaceutical company, and is there more on the way? In this video, Motley Fool health-care analyst David Williamson tells investors about the drug that has Acadia investors so excited, why it has so many competitive advantages, and what investors need to watch from here.
Acadia Leaps Toward the Finish Line
By Dave Williamson – Apr 11, 2013 at 6:22PM
NASDAQ: ACAD
Acadia Pharmaceuticals
Market Cap
$3.8B
Today's Change
(-0.35%) $0.08
Current Price
$22.66
Price as of October 31, 2025 at 10:09 AM ET
Shares of Acadia Pharmaceuticals exploded today. What's behind this stock price skyrocket?
About the Author
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Follow @motleydavid